Compounds That Target MAP2K3

mitogen-activated protein kinase kinase 3 · 16 compounds in BiohacksAI corpus

MAP2K3 (mitogen-activated protein kinase kinase 3) is a biological target with 16 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into MAP2K3 modulation for therapeutic and biohacking applications.

View MAP2K3 target page →UniProt: P46734 ↗

Most Studied Compounds for MAP2K3

Crizotinib

298+

studies

All 16 Compounds — Ranked by Evidence

Alvocidib

4.52

confidence

Ruxolitinib

4.23

confidence

Bosutinib

4.08

confidence

Midostaurin

3.85

confidence

Nintedanib

3.61

confidence

Tae 684

3.43

confidence

Fedratinib

3.40

confidence

Jnj 7706621

3.09

confidence

Lestaurtinib

3.04

confidence

R 406

2.83

confidence

Kw 2449

2.64

confidence

Ast 487

2.56

confidence

Ripasudil

2.40

confidence

Su 014813

2.20

confidence

Tg100 115

2.08

confidence

Crizotinib

298+

studies

0.69

confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for MAP2K3 (mitogen-activated protein kinase kinase 3). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: MAP2K3 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.